Skip to playerSkip to main contentSkip to footer
  • today
During a House Energy and Commerce Committee hearing on Tuesday, Rep. Erin Houchin (R-IN) spoke about an investigation into the Kentucky Organ Donor Affiliates, now known as Network for Hope.
Transcript
00:00The gentleman yields. The chair recognizes the gentlelady from Indiana, Ms.
00:04Houchen, for her five minutes of questioning. Thank you Mr. Chairman and
00:08congratulations on your chairmanship of this subcommittee. I'm grateful for the
00:13opportunity to weigh in on this extremely important topic. Every year
00:17tens of thousands of lives are saved because individuals make the courageous
00:21and selfless decision to donate their organs. The reality is organ donation is
00:25rare. Only about 1% of people who register as a donor are eligible to
00:29donate their organs at the time of death. That's why we must treat every case with
00:33the utmost care, integrity, and accountability. When we fail to maintain
00:37rigorous oversight and ensure ethical practices we risk eroding public
00:42confidence in the foundation of that system. Today's hearing not only touches
00:46on the safety of individual patients but the sustainability of the organ donation
00:50system. HRSA's report lays out deeply troubling findings particularly with
00:55respect to the actions of the Kentucky Organ Donor Affiliates or KYDA now called
01:02the Network for Hope. These findings hit particularly close to home for me as the
01:07organization under investigation serves my hometown community of Southern Indiana.
01:11The actions of KYDA to repeatedly continue to pursue organ recovery despite
01:18multiple signs of neurological function is not just alarming, it's morally and
01:22clinically indefensible. We are talking here about vulnerable patients, rural patients
01:28struggling with drug addiction, grieving families facing impossible decisions. When
01:35the public places trust in our organ procurement organizations, that trust must be earned and honored
01:40every single time. The failure to act upon clear signs of life, ignoring the pleading pressure
01:47by placed on by hospital staff, and the absence of non-partial accountability mechanisms raise serious
01:55questions about oversight and safeguards in the system. Dr. Lynch, your report makes it clear that existing
02:01protocols were not followed. Why did the oversight framework in place fail before the incidents were
02:09reported? And is it a broader systemic issue or is it limited to KYDA?
02:16Unfortunately, it is not limited to KYDA. During the course of this investigation, we received
02:25concerns that were in areas served by other OPOs. The failure here is at multiple levels. So the OPO
02:32has a responsibility to conduct quality reviews and to conduct good oversight, to conduct good training
02:39for its staff to make sure that they know what to look for and to make sure that they feel empowered to
02:44stop the process. These are all important things at a local level. HRSA's oversight here is through
02:50the OPTN on the system and the OPTN and its contractors review of this was poor.
02:55Thank you. I'm very concerned that we wouldn't know about this had it not been necessarily for the
03:03whistleblower who notified that wrote a letter to the committee alleging that a patient had been
03:12inaccurately pronounced brain dead and was pursued as an organ donor by KYDA. And per the report, the
03:17patient who was the victim of a drug overdose showed clear signs of life at multiple points. But KYDA
03:23senior staff directed that that the organ recovery proceed. We would not necessarily know about the
03:30depths that this has gone at KYDA were it not for that whistleblower who was subsequently fired by a
03:35procurement agency. Is that your understanding? Yes. So I'm concerned about what appears to be, and I think
03:44some of your testimony today reflects this, that there is an apparent conflict of interest in the
03:49oversight that HRSA is now working to correct. And I want to thank you for that on behalf of the constituents
03:55that I represent. But I wanted to get your thoughts on, you know, we talk about the ANRs that we know about with
04:03respect to DCD procurements. How many DCD procurements were completed by KYDA during the HRSA review process?
04:12Do you know that? I can't speak to, I can't recall to be perfectly honest the exact number, but it was,
04:20I believe that the ratio overall was about one to one, so on the order of 300 maybe. So you can understand
04:26that I might be concerned that the ANRs are just the ones that we know about, and that some that were
04:31completed, they were followed through with despite the warning signs that may have been present with
04:36the ANRs? That's a valid concern. Well I just want, in the remaining time I have, I know that that HRSA has
04:45asked OPTN to report on within 30 days some of their findings. Have you received anything from OPTN at this
04:54point that met your metric to develop and implement a 12-month monitoring plan for KYDA? Have they done
05:02that? Yes, we've started on that process and had meetings with them. Okay, they're supposed to issue
05:07that report on how they are going to monitor it. Have they done that? That is due at the end of this month.
05:13Okay, well I want to thank you for being here today. I look forward to us working together to improve
05:20accountability and transparency in our donation system. I remain concerned. It's clear there's
05:25a lot of work to be done to restore trust in the organ procurement network, particularly with respect
05:31to the troubling findings of KYDA. My last question with the time I have is, do you have concerns that
05:37KYDA is continuing under the current framework, given the concerns that have been shared to the committee?
05:44We believe that the corrective action plan that we're putting into place will enable them to perform
05:48in a safe fashion. Thank you.

Recommended